Target‐Based Antitubercular Drug Discovery: Scaffold Diversity and SAR Trends of Small Molecules Against Mycobacterium Tuberculosis
- 29 September 2026
- journal article
- review article
- Published by Wiley in Archiv der Pharmazie
- Vol. 359 (9) , e70347
Abstract
Tuberculosis remains a major infectious disease, and the increasing incidence of multidrug‐resistant Mycobacterium tuberculosis continues to limit current treatment options. This review summarizes recent medicinal chemistry efforts directed toward six important M. tuberculosis targets: InhA, DprE1, MmpL3, QcrB, DNA gyrase, and dihydrofolate reductase (DHFR). Emphasis is placed on the structural diversity and biological activity of potent molecules. SAR analysis relates changes in scaffold, substituent pattern, linker geometry, lipophilicity, and polarity to antimycobacterial potency and activity against resistant strains. Selected synthetic routes and clinically relevant antitubercular compounds are also discussed. Selected docking studies provide supportive structural information for representative potent inhibitors, while comparative SAR analysis provides an overview of the major structural features associated with activity across the target classes. Overall, the review summarizes recent medicinal chemistry advances in targeted antitubercular drug discovery and provides SAR considerations for further lead optimization.Keywords
This publication has 93 references indexed in Scilit:
- Rational Design, Synthesis, Biological Evaluation, and Molecular Modeling of Novel Thiazole‐Acetamide Derivatives as Antitubercular AgentsChemistrySelect, 2026
- 6-Phenoxyl-4-aminoquinoline: synthesis and preliminary antitubercular-structure activity relationship analysesMedicinal Chemistry Research, 2025
- Isoniazid‐Dihydropyrimidinone Molecular Hybrids: Design, Synthesis, Antitubercular Activity, and Cytotoxicity Investigations with Computational ValidationChemMedChem, 2025
- Synthesis of 6-dialkylaminopyrimidine carboxamide analogues and their anti-tubercular propertiesMedicinal Chemistry Research, 2024
- Inhibitor binding and disruption of coupled motions in MmpL3 protein: Unraveling the mechanism of trehalose monomycolate transportProtein Science, 2024
- A Green one-pot three component synthesis of thiazolidine-2,4-dione based bisspirooxindolo-pyrrolidines with [Bmim]BF4: their in vitro and in silico anti-TB studiesMolecular Diversity, 2024
- Synthesis,Antidiabetic and Antitubercular Evaluation of Quinoline–pyrazolopyrimidine hybrids and Quinoline‐4‐ArylaminesChemistryOpen, 2024
- Design, synthesis, anti-mycobacterial activity, molecular docking and ADME analysis of spiroquinoxaline-1,2,4-oxadiazoles via [3 + 2] cycloaddition reaction under ultrasound irradiationMolecular Diversity, 2024
- Design and synthesis of novel quinazolinyl-bisspirooxindoles as potent anti-tubercular agents: an ultrasound-promoted methodologyMolecular Diversity, 2022
- The first two cases of 2019‐nCoV in Italy: Where they come from?Journal of Medical Virology, 2020